USV Pvt. Ltd. has introduced OnArni, a fixed dose combination of Sacubitril and Valsartan, for the management of heart failure, priced at an accessible Rs. 8 per tablet for 50mg. This cost-effective ...

Mumbai: USV Pvt Ltd and Biogenomics announced the launch of INSUQUICK, India’s first biosimilar insulin aspart, which will improve access for people with diabetes. InsuQuick is a ‘Make in ...

Insulin aspart promises to be the stepping stone for USV’s entry into the insulin market, it claimed. USV Pvt Ltd and Biogenomics on Wednesday announced the launch of INSUQUICK, India’s first ...

Mumbai: The European Medicines Agency (EMA) has accepted for review of Mumbai-based pharmaceutical company USV Pvt. Ltd’s marketing application for biosimilar pegfilgrastim. The product is a bio ...

Sebamed, a German skincare brand marketed in India by USV Pvt. Ltd., has launched a new campaign titled ‘Project Skin Deep.’ From what is understood, the initiative focuses on exploring the ...

The campaign highlights the importance of motherhood in selecting trusted experts for baby care. Mumbai: Sebamed, a renowned German skincare and baby care brand, is marketed in India by USV Pvt.

Oral anti-diabetic drug maker USV Pvt Ltd on Wednesday announced fresh investment of Rs 400 crore on a new state-of-art formulations plant at Vadodara. The investment announcement comes on the ...